Zobrazeno 1 - 10
of 45
pro vyhledávání: '"higher dose"'
Publikováno v:
IET Nanobiotechnology, Vol 13, Iss 8, Pp 808-815 (2019)
Breast cancer is the second cause of death in the world. Ionising radiation is a potent mutagen that can cause DNA damage, chromosomes breakage, and cell death. In the present study, radiotherapy and nanoparticle‐antibodies (ABs) have been combined
Externí odkaz:
https://doaj.org/article/e8aaa0186cd94bba955587e4a57d60c5
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 27, Iss 11, Pp 508-513 (2011)
A 2-week, randomized, parallel-group open trial was designed to evaluate the safety and tolerability of a rapid initiation regimen with a higher dose of quetiapine (up to 800 mg/d by Day 4) than that used in the conventional initiation regimen of que
Externí odkaz:
https://doaj.org/article/b4ccfadabb4d418f8cca544070c52ed9
Autor:
Sabater-Abad J, Matellanes-Palacios M, Bou-Boluda L, Messeguer-Badia F, Agusti-Mejias A, Velasco-Pastor M, Lorente-Fernandez L, Gimeno-Carpio E
Publikováno v:
DERMATOLOGIC THERAPY
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Adalimumab (ADA) is a recombinant human monoclonal antibody indicated for the treatment of psoriasis that specifically inhibits tumor necrosis factor. Until recently we only had the presentation of 40 mg of ADA, being the standard dose in adults an i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::3c36e54c9e51f7ab212e7a79c1447401
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=10774
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=10774
Autor:
Joon Soo Lee, Jongsung Hahn, Se Hee Kim, Hoon Chul Kang, Min Jung Chang, Gyunam Park, Heung Dong Kim
Publikováno v:
Journal of Clinical Medicine, Vol 8, Iss 10, p 1591 (2019)
Journal of Clinical Medicine
Volume 8
Issue 10
Journal of Clinical Medicine
Volume 8
Issue 10
Hormone therapies and vigabatrin are first-line agents in infantile spasms, but more than one-third of patients fail to respond to these treatments. This was a retrospective study of patients with infantile spasms who were treated between January 200
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5f1da80369c12b15b0e84d1e5159946
https://www.mdpi.com/2077-0383/8/10/1591
https://www.mdpi.com/2077-0383/8/10/1591
Publikováno v:
EClinicalMedicine, Vol 26, Iss, Pp 100506-(2020)
EClinicalMedicine
EClinicalMedicine
Background Infantile hemangioma (IH) is common in children, which may bring about cosmetically disfiguring, functional impairment, and exhibiting complications. There had been various therapies and we aimed to assess the efficacy and adverse effects
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b6b1218f6f4fd74f2ef95a0042ec055
https://doi.org/10.1016/j.eclinm.2020.100506
https://doi.org/10.1016/j.eclinm.2020.100506
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 27, Iss 11, Pp 508-513 (2011)
A 2-week, randomized, parallel-group open trial was designed to evaluate the safety and tolerability of a rapid initiation regimen with a higher dose of quetiapine (up to 800 mg/d by Day 4) than that used in the conventional initiation regimen of que
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b9d476bf93baf106779e44fedd6027a
http://www.sciencedirect.com/science/article/pii/S1607551X11001355
http://www.sciencedirect.com/science/article/pii/S1607551X11001355
Autor:
José Luis Molinuevo, Giuseppe Bellelli, Tillmann Krahnke, Christine Strohmaier, Lutz Frölich, Jeffrey L. Cummings, George T. Grossberg
Publikováno v:
American journal of Alzheimer's disease and other dementias. 28(6)
Background: Stabilizing/reducing decline in the ability to perform activities of daily living (ADLs) is important in management of Alzheimer’s disease (AD). Methods: Post hoc analysis of OPtimizing Transdermal Exelon In Mild-to-moderate Alzheimer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b40bfd6cccbea92b4fddd822fb84434b
https://pubmed.ncbi.nlm.nih.gov/23982674
https://pubmed.ncbi.nlm.nih.gov/23982674
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.